Further validation of how Cellvizio is a complementary technology to manual and robotic-assisted bronchoscopy, potentially impacting patient management and improving outcomes in multiple pulmonology indicationsPARIS & BOSTON (BUSINESS WIRE) Regulatory News:Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQ.